Antti Kaipia

Medicine & Life Sciences

1. Finland 100%
2. Penile Neoplasms 95%
3. Prostatectomy 68%
4. Prostatic Neoplasms 62%
5. Postoperative Complications 42%
6. LH Receptors 30%
7. Patient Education 28%
8. Prostatitis 28%
9. Allopurinol 28%
10. Hyperuricemia 27%
11. Shared Decision Making 27%
12. Pelvic Pain 26%
13. Incidence 25%
14. Penis 25%
15. Testicular Neoplasms 25%
16. Transcranial Magnetic Stimulation 25%
17. Cancer Survivors 24%
18. Erectile Dysfunction 23%
19. Mortality 22%
20. Multicenter Studies 21%
21. Social Support 21%
22. Infections 21%
23. Visual Analog Scale 20%
24. Chronic Pain 20%
25. Prostate-Specific Antigen 19%
26. Quality of Health Care 19%
27. Emotions 17%
28. Catheters 17%
29. Therapeutics 17%
30. Delivery of Health Care 16%
31. Cohort Studies 16%
32. Prospective Studies 16%
33. Cross-Sectional Studies 15%
34. Registries 15%
35. Randomized Controlled Trials 15%
36. National Institutes of Health (U.S.) 14%
37. Prostate 13%
38. Biopsy 13%
39. Interviews 12%
40. Orthopedic Procedures 12%
41. Uric Acid 12%
42. Survival 12%
43. Urinary Bladder Neoplasms 12%
44. Population 11%
45. Luteinizing Hormone 10%
46. Neoplasms 10%
47. Urinary Catheters 9%
48. Pain 9%
49. Health Care Outcome Assessment 7%
50. Professional Education 7%